drugset / Trial / NCT05598242

Amniotic Membrane Treatment for Hyposecretory Dry Eye

NCT05598242

Phase 3 Completed 37 enrolled Hospital Nacional Profesor Alejandro Posadas
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this randomized, active-controlled, parallel-group trial is to evaluate the clinical efficacy of amniotic membrane extract eye drops (AMEED) in reducing signs and symptoms of hyposecretory dry eye Participants will receibed amniotic membrane extract eye drops 6 times daily and was evaluated at baseline day and day 30th. Researchers will compare against autologous serum eye drops effects

Timeline

Start
2019-02-01
Primary completion
2019-09-01
Completion
2019-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Amniotic Membrane Extract Unknown Other
Subject Autologous serum Unknown